Ukraine: EU Member States will need to prepare for possible increases in drug service demand
(18.07.2022) Since the Russian invasion of Ukraine on 24 February 2022, neighbouring EU countries have ensured a rapid humanitarian response, providing urgent support to meet the health and social needs of those fleeing the country.
EMCDDA training for Georgian drug treatment professionals
From 4 to 8 July, over five half days, Georgian professionals will receive online training on drug treatment interventions. Based on pre-assessed local needs and aligned with EU quality standards, the course focuses on responses to specific drugs and patterns of use.
Monitoring drug use in the digital age: web surveys show ‘great promise’
The online space has become increasingly relevant in identifying trends in illicit drug supply and demand. With increased internet activity globally, drug-related social interactions and purchases have also partially moved online.
EMCDDA launches foresight toolkit for the drugs field
Analysing potential futures to support decision-making today is increasingly used in a world characterised by rapid, volatile and complex change. More and more organisations, including EU bodies (1), are integrating foresight approaches into their activities.
Speech by EMCDDA Director, Alexis Goosdeel, on the occasion of the launch of the European Drug Report 2022, 14 June 2022
Good morning, First of all, I would like to express our warm thanks to Commissioner Ylva Johansson for her permanent support and also to Dr Franz Pietsch, the Chair of the EMCDDA Management Board. Are drugs different today? What can we do about this?
Speech by European Commissioner for Home Affairs, Ylva Johansson on the occasion of the launch of the European Drug Report 2022, 14 June 2022
Good morning everyone, We are presenting this year's European Drug Report at a time when we are celebrating 25 years of the EU Early Warning System. 25 years of alerting Europe to the dangers of new psychoactive substances, of new drugs.